These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17974945)
21. Review of the safety of disulfiram among dually diagnosed patients by Larson et al. Keller TW; Kivlahan DR Alcohol Clin Exp Res; 1992 Oct; 16(5):1004-5. PubMed ID: 1443416 [No Abstract] [Full Text] [Related]
23. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children. Eisenberg L Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174 [No Abstract] [Full Text] [Related]
24. Disulfiram and encephalopathy. Wilson WH Hosp Community Psychiatry; 1984 May; 35(5):496-7. PubMed ID: 6724545 [No Abstract] [Full Text] [Related]
25. The role of plasma amine oxidase, platelet monoamine oxidase, and red cell catechol-O-methyl transferase in severe behavioral reactions to disulfiram. Major LF; Murphy DL; Gershon ES; Brown GL Am J Psychiatry; 1979 May; 136(5):679-84. PubMed ID: 434246 [TBL] [Abstract][Full Text] [Related]
26. Disulfiram in the treatment of alcoholism; a review. Kwentus J; Major LF J Stud Alcohol; 1979 May; 40(5):428-46. PubMed ID: 381789 [No Abstract] [Full Text] [Related]
28. [On the problem of antabuse psychoses]. Reisner H; Kryspin-Exner K; Mader R; Schnaberth G Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):331-9. PubMed ID: 4241208 [No Abstract] [Full Text] [Related]
29. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Leonard BE; McCartan D; White J; King DJ Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851 [No Abstract] [Full Text] [Related]
30. [Psychotic complications after tetraethylthiuramdisulfide used in the treatment of alcoholism]. Skopková H Cesk Psychiatr; 1973 Apr; 69(2):102-11. PubMed ID: 4703132 [No Abstract] [Full Text] [Related]
31. Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram. Lake CR; Major LF; Ziegler MG; Kopin IJ Am J Psychiatry; 1977 Dec; 134(12):1411-4. PubMed ID: 920841 [TBL] [Abstract][Full Text] [Related]
32. Management of the disulfiram-alcohol reaction. Elenbaas RM J Maine Med Assoc; 1977 Jul; 68(7):236-40. PubMed ID: 881586 [No Abstract] [Full Text] [Related]
33. [On the genesis of "Antabuse psychoses" with special reference to cerebroelectric findings]. Boeters U; Reimer F Nervenarzt; 1968 Sep; 39(9):422-4. PubMed ID: 5712451 [No Abstract] [Full Text] [Related]
34. Vulnerability to disulfiram psychosis. Nasrallah HA West J Med; 1979 Jun; 130(6):575-7. PubMed ID: 516699 [No Abstract] [Full Text] [Related]
35. Drug therapy reviews: management of the disulfiram-alcohol reaction. Elenbaas RM Am J Hosp Pharm; 1977 Aug; 34(8):827-31. PubMed ID: 331944 [TBL] [Abstract][Full Text] [Related]
36. Amphetamine-type drugs for hyperactive children. Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553 [No Abstract] [Full Text] [Related]
37. Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action. Mutschler J; Diehl A; Kiefer F J Clin Psychopharmacol; 2009 Feb; 29(1):99-101. PubMed ID: 19142124 [No Abstract] [Full Text] [Related]
38. Methylphenidate (Ritalin) use and abuse. Crutchley A; Temlett JA S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063 [No Abstract] [Full Text] [Related]
39. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682 [TBL] [Abstract][Full Text] [Related]